Centogene NV (FRA:39K) Beginning Cash Position : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Beginning Cash Position?

Centogene NV's Beginning Cash Position for the quarter that ended in Jun. 2023 was €0.00 Mil.

Centogene NV's quarterly Beginning Cash Position declined from Jun. 2022 (€42.67 Mil) to Dec. 2022 (€0.00 Mil) but then stayed the same from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.00 Mil).

Centogene NV's annual Beginning Cash Position increased from Dec. 2020 (€41.10 Mil) to Dec. 2021 (€48.16 Mil) but then declined from Dec. 2021 (€48.16 Mil) to Dec. 2022 (€17.82 Mil).

Centogene NV Beginning Cash Position Historical Data

The historical data trend for Centogene NV's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Beginning Cash Position Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Beginning Cash Position

Get a 7-Day Free Trial

3.16

9.22

41.10

48.16

17.82

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Beginning Cash Position	Get a 7-Day Free Trial															25.70	17.82	42.67	-	-

Centogene NV Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Centogene NV Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Centogene NV's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (FRA:39K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (FRA:39K) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CNTG:USA 39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Centogene NV (FRA:39K) Headlines

No Headlines